+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Hemophilia Global Market Report 2024 - Product Thumbnail Image

Hemophilia Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Chronic Lymphocytic Leukemia Treatment Global Market Report 2024 - Product Thumbnail Image

Chronic Lymphocytic Leukemia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Bleeding Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Bleeding Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
South African Allergy Care Industry Landscape Report 2020 - Product Thumbnail Image

South African Allergy Care Industry Landscape Report 2020

  • Report
  • May 2020
  • 92 Pages
  • South Africa
From
From
From
From
Stroke Management Global Market Report 2024 - Product Thumbnail Image

Stroke Management Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
From
Neuromyelitis Optica Spectrum Disorder Market 2023-2027 - Product Thumbnail Image

Neuromyelitis Optica Spectrum Disorder Market 2023-2027

  • Report
  • June 2023
  • 138 Pages
  • Global
From
From
Loading Indicator